Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.41 |
| ▸ | NPY4R | P50391 | 8/20 | 0.38 |
| ▸ | NPY1R | P25929 | 6/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.38 |
| ▸ | NPY2R | P49146 | 5/20 | 0.38 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30962454 | 0.94 | NPY4R (0.39) | TERTNOD1NPY4RNPY1RNPY5R | |
| SCHEMBL30541579 | 0.92 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29587324 | 0.91 | ENPEP (0.42) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL607985 | 0.90 | NOD1 (0.40) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL607984 | 0.90 | NOD1 (0.40) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30563214 | 0.90 | NOD1 (0.40) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL10357149 | 0.90 | NOD1 (0.41) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL10357151 | 0.90 | NOD1 (0.41) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL9614927 | 0.89 | NPY4R (0.40) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15011349 | 0.89 | NPY4R (0.40) | NOD1NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-07 | — | — | US | claimed |
| CN-117642511-A | Secretion production method of protein containing unnatural amino acid | 味之素株式会社 | 2024-03-01 | — | — | CN | disclosed |
| CN-116057181-A | Methods and compositions for modifying and delivering lymphocytes | 埃克苏马生物技术公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115236337-A | Improved limulus kit for detecting industrial endotoxin based on dynamic color development method, and use method and application thereof | 丹娜(天津)生物科技股份有限公司 | 2022-10-25 | — | — | CN | disclosed |
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | F2RL1, F2R, F2RL3 | TERT 3511/4885NOD1 457/4885NPY4R 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.